--- title: "Pediatrix Medical Group (NYSE:MD) Shares Gap Down - What's Next?" type: "News" locale: "en" url: "https://longbridge.com/en/news/294848241.md" description: "Pediatrix Medical Group (NYSE:MD) shares gapped down, opening at $23.56 after closing at $26.25. Despite the drop, analysts maintain an average 'Hold' rating with a consensus target of $23.33. Recent financials showed Q2 EPS of $0.63 beating estimates, with revenue up 4.1%. Institutional ownership stands at 97.71%, while insider ownership is 1.80%." datetime: "2026-08-04T16:00:40.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294848241.md) - [en](https://longbridge.com/en/news/294848241.md) - [zh-HK](https://longbridge.com/zh-HK/news/294848241.md) generator: "portal-rs" --- # Pediatrix Medical Group (NYSE:MD) Shares Gap Down - What's Next? Pediatrix Medical Group, Inc. (NYSE:MD - Get Free Report)'s share price gapped down before the market opened on Tuesday . The stock had previously closed at $26.25, but opened at $23.56. Pediatrix Medical Group shares last traded at $26.4880, with a volume of 346,917 shares traded. ## Analyst Upgrades and Downgrades - MarketBeat Week in Review – 06/29 - 07/03 A number of analysts recently weighed in on the stock. Truist Financial increased their price target on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a "hold" rating in a research report on Tuesday, July 14th. UBS Group boosted their price objective on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the company a "neutral" rating in a report on Tuesday, May 12th. Mizuho set a $24.00 target price on shares of Pediatrix Medical Group in a research note on Friday, May 8th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Pediatrix Medical Group in a report on Wednesday, June 24th. Finally, Jefferies Financial Group reissued a "buy" rating and set a $27.00 price target on shares of Pediatrix Medical Group in a research report on Monday, April 20th. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $23.33. **View Our Latest Stock Analysis on MD** ## Pediatrix Medical Group Stock Performance - MDA Space Targets US Defense Market With $620M Acquisition The company has a debt-to-equity ratio of 0.45, a current ratio of 1.33 and a quick ratio of 1.33. The company has a market cap of $2.05 billion, a price-to-earnings ratio of 12.12 and a beta of 0.66. The stock has a 50-day moving average price of $24.70 and a 200 day moving average price of $22.52. Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.59 by $0.04. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.During the same period last year, the firm posted $0.53 earnings per share. Pediatrix Medical Group's revenue was up 4.1% compared to the same quarter last year. As a group, analysts anticipate that Pediatrix Medical Group, Inc. will post 2.1 EPS for the current fiscal year. ## Insider Buying and Selling at Pediatrix Medical Group - Medtronic Bottoms, Healthy Rebound Ahead In other news, Director Shirley A. Weis sold 36,028 shares of the stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total transaction of $855,665.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.80% of the stock is owned by company insiders. ## Institutional Investors Weigh In On Pediatrix Medical Group Several institutional investors have recently added to or reduced their stakes in the stock. Global Retirement Partners LLC raised its stake in shares of Pediatrix Medical Group by 68,250.0% in the 4th quarter. Global Retirement Partners LLC now owns 1,367 shares of the company's stock valued at $29,000 after purchasing an additional 1,365 shares during the period. Transamerica Financial Advisors LLC bought a new position in shares of Pediatrix Medical Group during the 4th quarter worth approximately $30,000. Eurizon Capital SGR S.p.A. bought a new position in shares of Pediatrix Medical Group during the 4th quarter worth approximately $33,000. Blue Trust Inc. acquired a new stake in shares of Pediatrix Medical Group in the fourth quarter valued at approximately $37,000. Finally, TD Private Client Wealth LLC acquired a new stake in shares of Pediatrix Medical Group in the fourth quarter valued at approximately $39,000. 97.71% of the stock is owned by institutional investors. ## Pediatrix Medical Group Company Profile (Get Free Report) Pediatrix Medical Group, Inc NYSE: MD is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology. Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings. ## Read More - Five stocks we like better than Pediatrix Medical Group - Apple’s AI Strategy Looks Different—Will It Pay Off? - The AI Chip Stock Making a Quiet Move Toward Dominance - Why Walmart and Amazon Could Be the Market’s Most Complementary Mega-Caps - Dodging Deutsche Telekom: T-Mobile's Strategic Win *This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.* ## Should You Invest $1,000 in Pediatrix Medical Group Right Now? Before you consider Pediatrix Medical Group, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list. While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [MD.US](https://longbridge.com/en/quote/MD.US.md) - [TFC.US](https://longbridge.com/en/quote/TFC.US.md) - [UBS.US](https://longbridge.com/en/quote/UBS.US.md) - [JEF.US](https://longbridge.com/en/quote/JEF.US.md) - [MDA.US](https://longbridge.com/en/quote/MDA.US.md) - [MDT.US](https://longbridge.com/en/quote/MDT.US.md) - [AAPL.US](https://longbridge.com/en/quote/AAPL.US.md) - [WMT.US](https://longbridge.com/en/quote/WMT.US.md) - [AMZN.US](https://longbridge.com/en/quote/AMZN.US.md) ## Related News & Research - [What is Zacks Research's Forecast for MD Q1 Earnings?](https://longbridge.com/en/news/296480548.md) - [Pediatrix Q2 2026 earnings: Reimbursement gains offset volume declines](https://longbridge.com/en/news/294919849.md) - [Pediatrix Medical beats Q2 revenue estimates, reaffirms 2026 adjusted EBITDA outlook](https://longbridge.com/en/news/294805273.md) - [Full Transcript: Pediatrix Medical Group Q2 2026 Earnings Call](https://longbridge.com/en/news/294834263.md) - [Sei Investments Co. Cuts Stock Holdings in Pediatrix Medical Group, Inc. $MD](https://longbridge.com/en/news/295295915.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**